Silk Road Medical, Inc. logo — Brighter patient outcomes through brighter clinical thinking

Silk Road Medical, Inc.

Brighter patient outcomes through brighter clinical thinking

Founded 2007 United States Sunnyvale, United States 419 employees Post Ipo Equity Total: $560.63M Health Care, Health and Wellness +1

General Information

Company Name Silk Road Medical, Inc.
Founded Year 2007
Location United States Sunnyvale, United States +2
Employees 419
Industries Health Care, Health and Wellness, Medical Devices
Funding Stage Post Ipo Equity
Social

Get notified when Silk Road Medical, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Silk Road Medical, Inc.

Silk Road Medical, Inc. is a health care startup based in Sunnyvale, California, founded in 2007. The company specializes in reducing the risk of stroke through its pioneering treatment of carotid artery disease, known as TransCarotid Artery Revascularization (TCAR). This clinically proven procedure combines neuroprotection principles with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE® Transcarotid Neuroprotection and Stent System is specifically designed for TCAR in high surgical risk patients. The company recently secured a significant $100.00M post-IPO equity investment on 18 October 2022. Silk Road Medical's innovative approach to stroke prevention in carotid artery disease sets it apart in the health care industry. The company's commitment to improving patient outcomes aligns with the growing focus on advanced medical devices designed to address critical health issues. With its recent substantial investment, Silk Road Medical is poised to further develop and expand its groundbreaking TCAR procedure, contributing to the advancement of stroke risk reduction in high-risk patients. For more information on the company, please visit their website at http://silkroadmed.com.

Taxonomy: Medical Device, TransCarotid Artery Revascularization, Stroke Prevention, Vascular Disease, Neuroprotection, Endovascular Techniques, Carotid Artery Disease, Surgical Innovation, Clinical Trial, Minimally Invasive Surgery, Vascular Specialists, Arterial Disease, Sunnyvale, California, ENROUTE Neuroprotection System, TCAR Procedure

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 18 Oct 2022
Post-IPO Debt •••••• 1 •••• •••• 31 May 2022
Debt Financing •••••• 1
Investor
01 Jan 2020
Series C •••••• 5
Investor Investor Investor Investor
•••• ••••
18 Jul 2017
Private Equity Round •••••• 3
Investor Investor Investor
20 Oct 2015

View All 10 Funding Rounds

FAQ About Silk Road Medical, Inc.

Brighter patient outcomes through brighter clinical thinking
Silk Road Medical, Inc. was founded in 2007.
Silk Road Medical, Inc. is headquartered in Sunnyvale, United States.
Silk Road Medical, Inc. operates in the following industries: Health Care, Health and Wellness, Medical Devices.
Silk Road Medical, Inc. has approximately 419 employees.
Silk Road Medical, Inc. has completed 10 funding rounds, raising a total of $560.63M. The latest funding stage is Post Ipo Equity.

We're actively collecting intelligence on Silk Road Medical, Inc..

Track Silk Road Medical, Inc. to get notified

Don't just browse. Track.

Signal Tracker monitors Silk Road Medical, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes